viral vectors is finding the right balance between safety and immunogenicity. Although live viral vaccine vectors are highly efficacious, there is also a greater potential risk involved with their broader ... there is…
vaccinations and the virus reactivation. However, reported cases of herpes zoster after viral vector COVID-19 vaccines were few. Case presentation: We report a case of a maxillary zoster ... immunocompetent female…
four vaccination formulas became available to the public, based on a viral vector or mRNA technology. These vaccine formulas have been hampered with hematological complications, like vaccine-induced immune thrombotic
cold-adapted influenza viruses contained in live attenuated influenza vaccine (LAIV) as vectors to deliver GBS antigens to the target cells. We analyzed immune epitopes of ScaAB protein and modeled ... exposed at the…
Viral vaccines and viral vectors processes present special challenges for virus safety. Viral clearance approaches traditionally used in biopharmaceutical products, such as size exclusion or chemical inactivation, are…
easily produced in cell lines. The most potent ChAd vectors were selected to generate vaccines for different pathogens including malaria, hepatitis C virus, Ebola and RSV. Solid preclinical data ... safety…
type 4(BoHV-4) is sparkling member of the attractive new emerging viral vectors in the vaccination and gene therapy fields. Several biological characteristics of bovine herpesvirus 4 (BoHV ... been proved. This…
interventions and an effective malaria vaccine could save half a million lives each year. We developed a prime-boost immunisation approach employing the viral vectors ChAd63 and MVA, both encoding ... IFNγ. We report…
order to induce the maximum immune responses, the priming recombinant viral vector should be antigenically distinct from the boost vaccine vector. We have engineered safer and highly efficient recombinant vesicular…
next generation of vaccines powered by innovations such as mRNA technology, nanoparticle-based vaccines, and viral vector platforms. These advancements not only promise faster and more efficient vaccine development
purpose of creating viral vectors and vaccines, the Vero cell line is thought to be the most often employed continuous cell line. It is the first cell line in history ... analyse the current literature on Vero cell…
progress in addressing emerging infectious diseases, the accelerateddevelopment of COVID-19 vaccines, and the evolution of mRNA, viral vector, protein subunit, DNA, and adjuvant-based vaccines.Furthermore, it explores…
Potent immunogenicity and lack of prolonged transgene expression have made Adenoviruses (Ad) attractive viral vectors for vaccine development. They possess a stable virion, allowing inserts of large foreign genes, they
Potent immunogenicity and lack of prolonged transgene expression have made Adenoviruses (Ad) attractive viral vectors for vaccine development. They possess a stable virion, allowing inserts of large foreign genes, they
malaria vaccines, and progress in tuberculosis, HPV, and dengue vaccine research. Fundamental innovations like adjuvant enhancement and viral vector platforms are crucial. Additionally, breakthroughs in cancer vaccines…
vectors has accelerated their applications in vaccine development. The versatility of alphavirus vectors has allowed their use in the form of recombinant viral particles, naked RNA and layered DNA molecules ... virus…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.